New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists

References

• American Psychiatric AssociationDiagnostic and statistical manual of mental disorders4th edition(DSM-IV), text revision. Washington, DCAmerican Psychiatric Association2000
   Google Scholar
• DrakeCLRoehrsTRothTInsomnia causes, consequences, and therapeutics: an overviewDepress Anxiety20031816317614661186
   PubMed Web of Science ®Google Scholar
• National Institutes of HealthNIH statement regarding the treatment of insomnia. State of the Science Conference Statement: Manifestations and management of chronic insomnia ind adultsSleep2005281049105716268373
   PubMed Web of Science ®Google Scholar
• SingerCTractenbergREKayeJSchaferKGamstAGrundmanMA multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer’s diseaseSleep20032689390114655926
   PubMed Web of Science ®Google Scholar
• SkeneDJSwaabDFMelatonin rhythmicity: effect of age and Alzheimer’s diseaseExp Gerontol20033819920612543278
   PubMed Web of Science ®Google Scholar
• SrinivasanVPandi-PerumalSRCardinaliDPPoeggelerBHardelandRMelatonin in Alzheimer’s disease and other neurodegenerative disordersBehav Brain Funct200621516674804
   PubMedGoogle Scholar
• WuYHSwaabDFDisturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer’s diseaseSleep Med2007862363617383938
   PubMed Web of Science ®Google Scholar
• LockleySWSkeneDJButlerLJArendtJSleep and activity rhythms are related to circadian phase in the blindSleep19992261662310450596
   PubMed Web of Science ®Google Scholar
• EbisawaTCircadian rhythms in the CNS and peripheral clock disorders: human sleep disorders and clock genesJ Pharmacol Sci200710315015417299246
   PubMed Web of Science ®Google Scholar
• OkawaMUchiyamaMCircadian rhythm sleep disorders and entrainment pathology in delayed sleep phase and non-24-h sleep-wake syndromeSleep Med Rev20071148549617964201
   PubMed Web of Science ®Google Scholar
• SkeneDJLockleySWArendtJUse of melatonin in the treatment of phase shift and sleep disordersAdv Exp Med Biol1999467798410721041
   PubMed Web of Science ®Google Scholar
• KameiYHayakawaTUrataJUchiyamaMShibuiKKimKMelatonin treatment for circadian rhythm sleep disordersPsychiatry Clin Neurosci200054391392
   Web of Science ®Google Scholar
• ZisapelNCircadian sleep disorders: pathophysiology and potential approaches to managementCNS Drugs20011531132811463135
   PubMed Web of Science ®Google Scholar
• SzeinbergABorodkinADaganYMelatonin treatment in adolescents with delayed sleep phase syndromeClin Pediatr (Phila)20064580981817041168
   PubMed Web of Science ®Google Scholar
• LiuCWeaverDRJinXShearmanLPPieschlRLGribkoffVKMolecular dissection of two distinct actions of melatonin on the suprachiasmatic clockNeuron199719911029247266
   PubMed Web of Science ®Google Scholar
• von GallCStehleJHWeaverDRMammalian melatonin receptors: molecular biology and signal transductionCell Tissue Res200230915116212111545
   PubMed Web of Science ®Google Scholar
• JinXvon GallCPieschlRLGribkoffVKStehleJHReppertSMTargeted disruption of the mouse Mel1b melatonin receptorMol Cell Biol2003231054106012529409
   PubMed Web of Science ®Google Scholar
• DubocovichMLMarkowskaMFunctional MT1 and MT2 melatonin receptors in mammalsEndocrine20052710111016217123
   PubMed Web of Science ®Google Scholar
• HardelandRMelatonin: Signaling mechanisms of a pleiotropic agentBioFactors20093518319219449447
   PubMed Web of Science ®Google Scholar
• Pandi-PerumalSRSrinivasanVPoeggelerBHardelandRCardinaliDPDrug insight: the use of melatonergic agonists for the treatment of insomnia – focus on ramelteonNat Clin Pract Neurol2007322122817410109
   PubMedGoogle Scholar
• HardelandRPoeggelerBSrinivasanVTrakhtIPandi-PerumalSRCardinaliDPMelatonergic drugs in clinical practiceArzneimittel-forschung20085811018368944
   PubMed Web of Science ®Google Scholar
• SrinivasanVPandi-PerumalSRTrahktISpenceDWPoeggelerBHardelandRMelatonin and melatonergic drugs on sleep: possible mechanisms of actionInt J Neurosci200911982184619326288
   PubMed Web of Science ®Google Scholar
• SaperCBScammellTELuJHypothalamic regulation of sleep and circadian rhythmsNature20054371257126316251950
   PubMed Web of Science ®Google Scholar
• FullerPMGooleyJJSaperCBNeurobiology of sleep-wake cycle, sleep architecture, circadian regulation and regulatory feed backJ Biol Rhythms20062148249317107938
   PubMed Web of Science ®Google Scholar
• ReppertSMGodsonCMahleCDWeaverDRSlaugenhauptSAGusellaJFMolecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptorProc Natl Acad Sci U S A199592873487387568007
   PubMed Web of Science ®Google Scholar
• MazzucchelliCPannacciMNonnoRLuciniVFraschiniFStankovBMThe melatonin receptor in the human brain: cloning experiments and distribution studiesBrain Res Mol Brain Res1996391171268804720
   PubMedGoogle Scholar
• ThomasLPurvisCCDrewJEAbramovichDRWilliamsLMMelatonin receptors in human fetal brain: 2-[125I]iodomelatonin binding and MT1 gene expressionJ Pineal Res20023321822412390504
   PubMed Web of Science ®Google Scholar
• Ambriz-TututiMRocha-GonzálezHICruzSLGranados-SotoVMelatonin: A hormone that modulates painLife Sci20098448949819223003
   PubMed Web of Science ®Google Scholar
• DijkDJRothCLandoltHPWerthEAeppliMAchermannPMelatonin effect on daytime sleep in men: suppression of EEG low frequency activity and enhancement of spindle frequency activityNeurosci Lett199520113168830301
   PubMed Web of Science ®Google Scholar
• JanJEReiterRJWasdellMBBaxMThe role of the thalamus in sleep, pineal melatonin production, and circadian rhythm sleep disordersJ Pineal Res2009461718761566
   PubMed Web of Science ®Google Scholar
• De GennaroLFerraraMSleep spindles. An overviewSleep Med Rev2003742344014573378
   PubMed Web of Science ®Google Scholar
• MorinLPAllenCNThe circadian visual system, 2005Brain Res Rev20065116016337005
   PubMedGoogle Scholar
• JanJEWasdellMBReiterRJWeissMDJohnsonKPIvanenkoAMelatonin therapy of pediatric sleep disorders: recent advances, why it works, who are the candidates and how to treatCurr Pediatr Rev20073214224
   Google Scholar
• CajochenCMünchMKnoblauchVBlatterKWirz-JusticeAAge-related changes in the circadian and homeostatic regulation of human sleepChronobiol Int20062346147416687319
   PubMed Web of Science ®Google Scholar
• GorfineTZisapelNLate evening brain activation patterns and their relation to the internal biological time, melatonin, and homeostatic sleep debtHum Brain Mapp20093054155218095278
   PubMed Web of Science ®Google Scholar
• DijkDJvon SchantzMTiming and consolidation of human sleep, wakefulness, and performance by a symphony of oscillatorsJ Biol Rhythms20052027929016077148
   PubMed Web of Science ®Google Scholar
• CajochenCKräuchiKWirz-JusticeARole of melatonin in the regulation of human circadian rhythms and sleepJ Neuroendocrinol20031543243712622846
   PubMed Web of Science ®Google Scholar
• HardelandRAntioxidative protection by melatonin – Multiplicity of mechanisms from radical detoxification to radical avoidanceEndocrine20052711913016217125
   PubMed Web of Science ®Google Scholar
• LuJShermanDDevorMSaperCBA putative flip-flop switch for control of REM sleepNature200644158959416688184
   PubMed Web of Science ®Google Scholar
• FullerPMSaperCBLuJThe pontine REM switch: past and presentJ Physiol200758473574117884926
   PubMed Web of Science ®Google Scholar
• KunzDMahlbergRMüllerCTilmannABesFMelatonin in patients with reduced REM sleep duration: two randomized controlled trialsJ Clin Endocrinol Metab20048912813414715839
   PubMed Web of Science ®Google Scholar
• ClaustratBBrunJChazotGThe basic physiology and pathophysiology of melatoninSleep Med Rev20059112415649735
   PubMed Web of Science ®Google Scholar
• HardelandRPoeggelerBActions of melatonin, its structural and functional analogs in the central nervous system and the significance of metabolismCent Nerv Syst Agents Med Chem10077289303
   Google Scholar
• HardelandRPoeggelerBMelatonin beyond its classical functionsOpen Physiol J20081123
   Google Scholar
• HardelandRMelatonin, hormone of darkness and more – occurrence, control mechanisms, actions and bioactive metabolitesCell Mol Life Sci2008652001201818344019
   PubMed Web of Science ®Google Scholar
• KatoKHiraiKNishiyamaKUchikawaOFukatsuKOhkawaSNeurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonistNeuropharmacology20054830131015695169
   PubMed Web of Science ®Google Scholar
• PoeggelerBHardelandRMelatoninerge Chronobiotika: Wirkungen und ProblemeHardelandRFacetten der Chronobiologie Abh Leibniz-Soz23BerlinTrafo20087187
   Google Scholar
• MaXIdleJRKrauszKWGonzalezFJMetabolism of melatonin by human cytochromes p450Drug Metab Dispos20053348949415616152
   PubMed Web of Science ®Google Scholar
• Pandi-PerumalSRSrinivasanVMaestroniGJMCardinaliDPPoeggelerBHardelandRMelatonin – Nature’s most versatile biological signal?FEBS J20062732813283816817850
   PubMed Web of Science ®Google Scholar
• FeldsteinAChangFHKucharskiJMTryptophol, 5-hydroxytryptophol and 5-methoxytryptophol induced sleep in miceLife Sci197093233295444013
   PubMedGoogle Scholar
• EMEA. Assessment report for Circadin200752 p. Available from: http.//www.emea.europe.eu/humandocs/PDFs/EPAR/Circadin/H-695-eu6.pdf
   Google Scholar
• HuetherGMessnerMRodenbeckAHardelandREffect of continuous melatonin infusions on steady-state plasma melatonin levels in rats under near physiological conditionsJ Pineal Res1998241461519551851
   PubMed Web of Science ®Google Scholar
• HajakGHuetherGBlankeJBlömerMFreyerCPoeggelerBThe influence of intravenous L-tryptophan on plasma melatonin and sleep in menPharmacopsychiatry19912417202011617
   PubMed Web of Science ®Google Scholar
• BubenikGAGastrointestinal melatonin: localization, function, and clinical relevanceDig Dis Sci2002472336234812395907
   PubMed Web of Science ®Google Scholar
• HardelandRPandi-PerumalSRMelatonin, a potent agent in antioxidative defense: Actions as a natural food constituent, gastrointestinal factor, drug and prodrugNutr Metab (Lond)22005article no 22 [DOI 10.1186/1743-7075-2-22].
   Google Scholar
• PoeggelerBCornélissenGHuetherGHardelandRJózsaRZemanMChronomics affirm extending scope of lead in phase of duodenal vs pineal circadian melatonin rhythmsBiomed Pharmacother200559S220S22416275498
   PubMed Web of Science ®Google Scholar
• TanDXManchesterLCReiterRJQiWHanesMAFarleyNJHigh physiological levels of melatonin in the bile of mammalsLife Sci1999652523252910622237
   PubMed Web of Science ®Google Scholar
• MessnerMHuetherGLorfTRamadoriGSchwörerHPresence of melatonin in the human hepatobiliary-gastrointestinal tractLife Sci20016954355111510949
   PubMed Web of Science ®Google Scholar
• HuetherGMelatonin synthesis in the gastrointestinal tract and the impact of nutritional factors on circulating melatoninAnn N Y Acad Sci19947191461588010590
   PubMed Web of Science ®Google Scholar
• LeeBJRyuSGChoiHGKimCKParrottKAAyresJWBatch variation and pharmacokinetics of oral sustained release melatonin-loaded sugar spheres in human subjectsArch Pharm Res19972055555918982259
   PubMed Web of Science ®Google Scholar
• PrianoLEspostiDEspostiRCastagnaGDe MediciCFraschiniFSolid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systemsJ Nanosci Nanotechnol200773596360118330178
   PubMed Web of Science ®Google Scholar
• MulchaheyJJGoldwaterDRZemlanFPA single blind, placebo controlled, across groups dose escalation study of the safety, tolerability, pharmacokinetics and pharmacodynamics of the melatonin analog β-methyl-6-chloromelatoninLife Sci2004751843185615302228
   PubMed Web of Science ®Google Scholar
• ZemlanFPMulchaheyJJScharfMBMaylebenDWRosenbergRLankfordAThe efficacy and safety of the melatonin agonist β-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trialJ Clin Psychiatry20056638439015766306
   PubMed Web of Science ®Google Scholar
• EMEAQuestions and answers on recommendation for the refusal of the marketing authorisation for ramelteon. Press Release, May 30, 2008. http://www.emea.europa.eu/pdfs/human/opinion/Ramelteon_26821608en.pdf
   Google Scholar
• EMEATakeda withdraws its marketing authorisation application for Ramelteon. Press Release, September 25, 2008. http://www.emea.europa.eu/humandocs/PDFs/EPAR/ramelteon/50471608en.pdf
   Google Scholar
• MiyamotoMNishikawaHOhtaHUchikawaOOhkawaOOhkawaSBehavioural pharmacology of TAK-375 in small animalsAnn Neurol200354S4612891653
   PubMed Web of Science ®Google Scholar
• McGechanAWellingtonKRamelteonCNS Drugs2005191057106516332146
   PubMed Web of Science ®Google Scholar
• KarimATolbertDCaoCDisposition kinetics and tolerance of escalating single doses of ramelteon, a high affinity MT1 and MT2 melatonin receptor agonist indicated for the treatment of insomniaJ Clin Pharmacol20064614014816432265
   PubMed Web of Science ®Google Scholar
• RajaratnamSMPolymeropoulosMHFisherDMRothTScottCBirznieksGMelatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trialsLancet200937348249119054552
   PubMed Web of Science ®Google Scholar
• KlermanEBMelatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. Web Appendix to online prepublication of ref. 53. 2008www.thelancet.com
   Google Scholar
• VachharajaniNNYeleswaramKBoultonDWPreclinical pharmacokinetics and metabolism of BMS-214778, a novel melatonin receptor agonistJ Pharm Sci20039276077212661062
   PubMed Web of Science ®Google Scholar
• IDdb Author. Associated Professional Sleep Societies – 20 Annual Meeting (Part I), Hypnotic and Wake-promoting Drugs, Salt Lake City, UT, USA. IDdb Meeting Report; 2006, June 17–22.
   Google Scholar
• ZhuMMitrokaJShawAALukeGMVachharajaniNKripalaniKJIdentification of in vitro and in vivo metabolites of BMS-214778 in monkeys by ion trap LC/MS and LC/NMRDrug Metab Rev200032Suppl 2260
   Google Scholar
• MillanMJGobertALejeuneFDekeyneANewman-TancrediAPasteauVThe novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathwaysJ Pharmacol Exp Ther200330695496412750432
   PubMed Web of Science ®Google Scholar
• Servier PharmaValdoxan® (agomelatine), a novel antidepressant, receives European marketing authorizationServier Press Release2009http://www.agomelatine.org/2009-valdoxan.html
   Google Scholar
• CarrRWasdellMBHamiltonDWeissMDFreemanRDTaiJLong-term effectiveness outcome of melatonin therapy in children with treatment-resistant circadian rhythm sleep disordersJ Pineal Res20074335135917910603
   PubMed Web of Science ®Google Scholar
• WadeAGFordICrawfordGMcMahonADNirTLaudonMEfficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness outcomesCurr Med Res Opin2007232597260517875243
   PubMed Web of Science ®Google Scholar
• LemoinePNirTLaudonMZisapelNProlonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effectsJ Sleep Res20071637238018036082
   PubMed Web of Science ®Google Scholar
• HaimovILaviePLaudonMHererPVigderCZisapelNMelatonin replacement therapy of elderly insomniacsSleep1995185986038552931
   PubMed Web of Science ®Google Scholar
• SuhnerASchlagenhaufPJohnsonRTschoppASteffenRComparative study to determine the optimal melatonin dosage form for the alleviation of jet lagChronobiol Int1998156556669844753
   PubMed Web of Science ®Google Scholar
• HerxheimerAPetrieKKJMelatonin for the prevention and treatment of jet lagCochrane Database Syst Rev20022article no. CD001520. DOI: 10.1002/14651858.CD001520.
   Google Scholar
• PaulMAGrayGSardanaTMPigeauRAMelatonin and zopiclone as facilitators of early circadian sleep in operational air transport crewsAviat Space Environ Med20047543944315152897
   PubMed Web of Science ®Google Scholar
• SharkeyKMFoggLFEastmanCIEffects of melatonin administration on daytime sleep after simulated night shift workJ Sleep Res20011018119211696071
   PubMed Web of Science ®Google Scholar
• CrowleySJLeeCTsengCYFoggLFEastmanCICombinations of bright light, scheduled dark, sunglasses, and melatonin to facilitate circadian entrainment to night shift workJ Biol Rhythms20031851352314667152
   PubMed Web of Science ®Google Scholar
• JanJEHamiltonDSewardNFastDKFreemanRDLaudonMClinical trials of controlled-release melatonin in children with sleep-wake cycle disordersJ Pineal Res200029343910949538
   PubMed Web of Science ®Google Scholar
• WasdellMBJanJEBombenMMFreemanRDRietveldWJTaiJA randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilitiesJ Pineal Res200844576418078449
   PubMed Web of Science ®Google Scholar
• PotockiLGlazeDTanDXParkSSKashorkCDShafferLGCircadian rhythm abnormalities of melatonin in Smith-Magenis syndromeJ Med Genet20003742843310851253
   PubMed Web of Science ®Google Scholar
• De LeersnyderHInverted rhythm of melatonin secretion in Smith-Magenis syndrome: from symptoms to treatmentTrends Endocrinol Metab20061729129816890450
   PubMed Web of Science ®Google Scholar
• De LeersnyderHClaustratBMunnichAVerloesACircadian rhythm disorder in a rare disease: Smith-Magenis syndromeMol Cell Endocrinol2006252889116723183
   PubMed Web of Science ®Google Scholar
• CarpizoRMartínezAMediavillaDGonzálezMAbadASánchez-BarcelóEJSmith-Magenis syndrome: a case report of improved sleep after treatment with β1-adrenergic antagonists and melatoninJ Pediatr200614940941116939758
   PubMed Web of Science ®Google Scholar
• JanJEEspezelHAppletonREThe treatment of sleep disorders with melatoninDev Med Child Neurol199436971078132132
   PubMed Web of Science ®Google Scholar
• McArthurAJBuddenSSSleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatmentDev Med Child Neurol1998401861929566656
   PubMed Web of Science ®Google Scholar
• IshizakiASugamaMTakeuchiN[Usefulness of melatonin for developmental sleep and emotional/behavior disorders–studies of melatonin trial on 50 patients with developmental disorders.] [in Japanese]No To Hattatsu19993142843710487068
   PubMedGoogle Scholar
• AndersenIMKaczmarskaJMcGrewSGMalowBAMelatonin for insomnia in children with autism spectrum disordersJ Child Neurol20082348248518182647
   PubMed Web of Science ®Google Scholar
• GiannottiFCortesiFCerquigliniABernabeiPAn open-label study of controlled-release melatonin in treatment of sleep disorders in children with autismJ Autism Dev Disord20063674175216897403
   PubMed Web of Science ®Google Scholar
• DolbergOTHirschmannSGrunhausLMelatonin for the treatment of sleep disturbances in major depressive disorderAm J Psychiatry1998155111911219699707
   PubMed Web of Science ®Google Scholar
• DaltonEJRotondiDLevitanRDKennedySHBrownGMUse of slow-release melatonin in treatment-resistant depressionJ Psychiatry Neurosci200025485210721684
   PubMed Web of Science ®Google Scholar
• ShiloLDaganYSmorjikYWeinbergUDolevSKomptelBEffect of melatonin on sleep quality of COPD intensive care patients: a pilot studyChronobiol Int200017717610672435
   PubMed Web of Science ®Google Scholar
• ShamirELaudonMBarakYAnisYRotenbergVElizurAMelatonin improves sleep quality of patients with chronic schizophreniaJ Clin Psychiatry20006137337710847313
   PubMed Web of Science ®Google Scholar
• ShamirERotenbergVSLaudonMZisapelNElizurAFirst-night effect of melatonin treatment in patients with chronic schizophreniaJ Clin Psychopharmacol20002069169411106143
   PubMed Web of Science ®Google Scholar
• SerfatyMKennell-WebbSWarnerJBlizardRRavenPDouble blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementiaInt J Geriatr Psychiatry2002171120112712461760
   PubMed Web of Science ®Google Scholar
• BorjaNLDanielKLRamelteon for the treatment of insomniaClin Ther2006281540155517157111
   PubMed Web of Science ®Google Scholar
• NeubauerDNA review of ramelteon in the treatment of sleep disordersNeuropsychiatr Dis Treat20084697918728808
   PubMedGoogle Scholar
• RothTSeidenDSainatiSWang-WeigandSZhangJZeePEffects of ramelteon on patient-reported sleep latency in older adults with chronic insomniaSleep Med2006731231816709464
   PubMed Web of Science ®Google Scholar
• ErmanMSeidenDZammitGSainatiSZhangJAn efficacy, safety, and dose-response study of ramelteon in patients with chronic primary insomniaSleep Med20067172416309958
   PubMed Web of Science ®Google Scholar
• RothTSeidenDWang-WeigandSZhangJA 2-night, 3-period, crossover study on ramelteon’s efficacy and safety in older adults with chronic insomniaCurr Med Res Opin2007231005101417519067
   PubMed Web of Science ®Google Scholar
• ZammitGErmanMWang-WeigandSSainatiSZhangJRothTEvaluation of the efficacy and safety of ramelteon in subjects with chronic insomniaJ Clin Sleep Med2007349550417803013
   PubMed Web of Science ®Google Scholar
• KrygerMWang-WeigandSRothTSafety of ramelteon in individuals with mild to moderate obstructive sleep apneaSleep Breath20071115916417294232
   PubMed Web of Science ®Google Scholar
• OtmaniSDemazièresAStanerCJacobNNirTZisapelNEffects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteersHum Psychopharmacol20082369370518763235
   PubMed Web of Science ®Google Scholar
• GarfinkelDZisapelNWainsteinJLaudonMFacilitation of benzodiazepine discontinuation by melatonin: a new clinical approachArch Intern Med19991592456246010665894
   PubMed Web of Science ®Google Scholar
• WeishauptJHBartelsCPölkingEDietrichJRohdeGPoeggelerBReduced oxidative damage in ALS by high-dose enteral melatonin treatmentJ Pineal Res20064131332317014688
   PubMed Web of Science ®Google Scholar
• SilmanREMelatonin: a contraceptive for the ninetiesEur J Obstet Gynecol Reprod Biol199349398365512
   PubMed Web of Science ®Google Scholar
• García-PattersonAPuig-DomingoMWebbSMThirty years of human pineal research: do we know its clinical relevance?J Pineal Res199620168648556
   PubMed Web of Science ®Google Scholar
• BubenikGABlaskDEBrownGMMaestroniGJPangSFReiterRJProspects of the clinical utilization of melatoninBiol Signals Recept199871952199730580
   PubMedGoogle Scholar
• SilmanRMelatonin and the human gonadotrophin-releasing hormone pulse generatorJ Endocrinol19911287111999677
   PubMed Web of Science ®Google Scholar
• WaldhauserFBoepplePASchemperMMansfieldMJCrowleyWFJrSerum melatonin in central precocious puberty is lower than in age-matched prepubertal childrenJ Clin Endocrinol Metab1991737937961909703
   PubMed Web of Science ®Google Scholar
• WalkerABEnglishJArendtJMacFarlaneIAHypogonadotrophic hypogonadism and primary amenorrhoea associated with increased melatonin secretion from a cystic pineal lesionClin Endocrinol (Oxf)1996453533568949574
   PubMed Web of Science ®Google Scholar
• LuboshitzkyRHererPShen-OrrZUrinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatmentExp Clin Endocrinol Diabetes200411210210715031776
   PubMed Web of Science ®Google Scholar
• RohrUDHeroldJMelatonin deficiencies in womenMaturitas200241Suppl 1S85S10411955797
   PubMed Web of Science ®Google Scholar
• LuboshitzkyRLeviMShen-OrrZBlumenfeldZHererPLaviePLong-term melatonin administration does not alter pituitary-gonadal hormone secretion in normal menHum Reprod200015606510611189
   PubMed Web of Science ®Google Scholar
• LuboshitzkyRShen-OrrZNaveRLaviSLaviePMelatonin administration alters semen quality in healthy menJ Androl20022357257812065466
   PubMedGoogle Scholar
• PalmLBlennowGWetterbergLLong-term melatonin treatment in blind children and young adults with circadian sleep-wake disturbancesDev Med Child Neurol1997393193259236698
   PubMed Web of Science ®Google Scholar
• JanJEFreemanRDFastDKMelatonin treatment of sleep-wake cycle disorders in children and adolescentsDev Med Child Neurol19994149150010454235
   PubMed Web of Science ®Google Scholar
• DodgeNNWilsonGAMelatonin for treatment of sleep disorders in children with developmental disabilitiesJ Child Neurol20011658158411510929
   PubMed Web of Science ®Google Scholar
• Takeda Pharmaceuticals America, IncRozerem™ (ramelteon) tablets. 05-1118;L-RAM-00010. 2005
   Google Scholar
• WillisGLParkinson’s disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative processRev Neurosci20081924531619145986
   PubMed Web of Science ®Google Scholar
• WillisGLThe role of ML-23 and other melatonin analogues in the treatment and management of Parkinson’s diseaseDrug News Perspect20051843744416362083
   PubMed Web of Science ®Google Scholar
• OsadchukAMOsadchukMAKvetnoIM[Irritated bowel syndrome: clinico-morphological types.] [Article in Russian]Klin Med (Mosk)200785465017523405
   PubMedGoogle Scholar
• HardelandRPandi-PerumalSRCardinaliDPMolecules in focus – MelatoninInt J Biochem Cell Biol20063831331616219483
   PubMed Web of Science ®Google Scholar
• FavaMAsnisGShrivastavaRLydiardRBBastaniBSheehanDImproved insomnia symptoms and daily functioning in patients with comorbid major depressive disorder and insomnia following zolpidem extended-release 12.5 mg and escitalopram co-treatmentSleep200831A324
   Web of Science ®Google Scholar
• KrygerMRothTWang-WeigandSZhangJThe effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary diseaseSleep Breath200913798418584227
   PubMed Web of Science ®Google Scholar
• RothTHypnotic use for insomnia management in chronic obstructive pulmonary diseaseSleep Med200910192518693067
   PubMed Web of Science ®Google Scholar
• NunesDMMotaRMMachadoMOPereiraEDde BruinVMde BruinPFEffect of melatonin administration on subjective sleep quality in chronic obstructive pulmonary diseaseBraz J Med Biol Res20084192693119030713
   PubMed Web of Science ®Google Scholar